Results 31 to 40 of about 9,288,830 (350)

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

open access: yesJournal of Clinical Oncology, 2020
PURPOSE Many patients with HR+, HER2− early breast cancer (EBC) will not experience recurrence or have distant recurrence with currently available standard therapies.
S. Johnston   +28 more
semanticscholar   +1 more source

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial

open access: yesClinical Cancer Research, 2021
Purpose: Ribociclib plus endocrine therapy (ET) demonstrated a statistically significant progression-free survival and overall survival (OS) benefit in the phase III MONALEESA-7 trial of pre-/perimenopausal patients with hormone receptor (HR)-positive ...
Yen-Shen Lu   +27 more
semanticscholar   +1 more source

The research progress of endocrine therapy combined with targeted therapy for triple-positive breast cancer [PDF]

open access: yesZhongguo aizheng zazhi, 2023
Triple-positive breast cancer (TPBC) refers to breast cancer with positive expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2), accounting for 5%-10% of all pathological types of breast cancer.
Xiaoshan CAO, Binbin CONG
doaj   +2 more sources

Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.

open access: yesThe Lancet Oncology, 2021
The growing availability of more effective therapies has contributed to an increased survival of patients with breast cancer. In hormone receptor-positive early disease, increased survival is strongly correlated with the use of adjuvant endocrine therapy,
M. Franzoi   +7 more
semanticscholar   +1 more source

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer

open access: yesChinese Medical Journal, 2020
. Increasing numbers of targeted drugs are used in hormone receptor (HR)-positive metastatic breast cancer (MBC) to overcome or delay resistance to endocrine therapy.
Li Bian   +3 more
doaj   +1 more source

A hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer [PDF]

open access: yes, 2014
Objective: To explore women’s experiences of taking adjuvant endocrine therapy as a treatment for breast cancer and how their beliefs about the purpose of the medication, side effects experienced and interactions with health professionals might influence
McCowan, Colin   +17 more
core   +1 more source

Endocrine Therapy

open access: yesMinnesota medicine, 2010
The link between ovarian hormones and breast cancer began to be formed as early as 1882 when TW Nunn observed the spontaneous regression of breast cancer in a woman 6 months after her menstruation ceased [1]. Oophorectomy was first proposed by the German clinician, Schinzinger, on the basis of his observation that younger women had more aggressive ...
Howell, Sacha J.; id_orcid 0000-0001-8141-6515   +1 more
openaire   +4 more sources

Endocrine aspects of cancer gene therapy [PDF]

open access: yes, 2004
The field of cancer gene therapy is in continuous expansion, and technology is quickly moving ahead as far as gene targeting and regulation of gene expression are concerned.
BOSCARO, MARCO   +5 more
core   +1 more source

Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy

open access: yesCancers, 2022
Simple Summary Breast cancer is the leading cause of cancer-related deaths in the female population, with estrogen receptor (ER)-positive breast cancer accounting for two-third of incidents. Endocrine therapy has proven beneficial in treating ER-positive
A. Kawiak, A. Kostecka
semanticscholar   +1 more source

Perceptions of Endocrine Therapy in African-American Breast Cancer Survivors: Mixed Methods Study

open access: yesJMIR Formative Research, 2021
BackgroundAlthough the incidence of breast cancer is lower in African-American women than in White women, African-American women have a decreased survival rate.
Donevant, Sara   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy